Carotid intima-media thickness and cardiovascular risk

被引：13

作者：

Mookadam, Farouk ^{[1
]}

Tanasunont, Weerawat ^{[1
]}

Jalal, Uzma ^{[1
]}

Mookadam, Martina ^{[1
]}

Wilansky, Susan ^{[1
]}

机构：

[1] Mayo Clin Scottsdale, Dept Cardiovasc Dis, Scottsdale, AZ 85259 USA

来源：

FUTURE CARDIOLOGY | 2011年 / 7卷 / 02期

关键词：

atherosclerosis; cardiovascular risk; carotid intima-media thickness; screening;

D O I：

10.2217/FCA.11.2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiovascular disease is the primary cause of death in most developed nations. Identifying an individual's cardiovascular risk remains a challenge. Traditional coronary-risk stratification is based on cardiovascular risk factors using risk score systems, which may not reliably identify atherosclerosis in asymptomatic individuals. Carotid intima-media thickness measured by ultrasonography is a noninvasive, wellvalidated tool that has been used as a surrogate for clinical coronary events. Carotid intima-media thickness has demonstrable utility as an independent predictor of future cardiovascular events. Recent data have improved our understanding of its application as a screening tool for cardiovascular disease.

引用

页码：173 / 182

页数：10

共 40 条

[1]

[Anonymous], 2002, LANCET, V360, P7

[2] Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria [J].

Asselbergs, FW ;

Diercks, GFH ;

Hillege, HL ;

van Boven, AJ ;

Janssen, WMT ;

Voors, AA ;

de Zeeuw, D ;

de Jong, PE ;

van Veldhuisen, DJ ;

van Gilst, WH .

CIRCULATION, 2004, 110 (18) :2809-2816

[3]

Baguet JP, 2009, VASC HEALTH RISK MAN, V5, P175

[4] Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study [J].

Bots, M. L. ;

Palmer, M. K. ;

Dogan, S. ;

Plantinga, Y. ;

Raichlen, J. S. ;

Evans, G. W. ;

O'Leary, D. H. ;

Grobbee, D. E. ;

Crouse, J. R., III .

JOURNAL OF INTERNAL MEDICINE, 2009, 265 (06) :698-707

[5]

Chambless LE, 2000, AM J EPIDEMIOL, V151, P478

[6] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].

Downs, JR ;

Clearfield, M ;

Weis, S ;

Whitney, E ;

Shapiro, DR ;

Beere, PA ;

Langendorfer, A ;

Stein, EA ;

Kruyer, W ;

Gotto, AM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622

[7] Effect of Statins Alone Versus Statins Plus Ezetimibe on Carotid Atherosclerosis in Type 2 Diabetes [J].

Fleg, Jerome L. ;

Mete, Mihriye ;

Howard, Barabara V. ;

Umans, Jason G. ;

Roman, Mary J. ;

Ratner, Robert E. ;

Silverman, Angela ;

Galloway, James M. ;

Henderson, Jeffrey A. ;

Weir, Matthew R. ;

Wilson, Charlton ;

Stylianou, Mario ;

Howard, Wm. James .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (25) :2198-2205

[8]

Greenland P, 2000, CIRCULATION, V101, P723

[9] Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness -: Main results from the β-blocker cholesterol-lowering asymptomatic plaque study (BCAPS) [J].

Hedblad, B ;

Wikstrand, J ;

Janzon, L ;

Wedel, H ;

Berglund, G .

CIRCULATION, 2001, 103 (13) :1721-1726

[10] Comparison between measures of atherosclerosis and risk of stroke - The Rotterdam Study [J].

Hollander, M ;

Hak, AE ;

Koudstaal, PJ ;

Bots, ML ;

Grobbee, DE ;

Hofman, A ;

Witteman, JCM ;

Breteler, MMB .

STROKE, 2003, 34 (10) :2367-2372

← 1 2 3 4 →